Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability

<div>Histopathological conditions of nasal mucosa after treatment with (a) phosphate buffer saline (PBS) pH 6.4. (b) Isopropyl alcohol. (c) SLN formulation.</div>

BioMed Research International

fig8

Figure 8

Figure 8: Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability 

Figure 8 | Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability 